Peripheral blood samples (HLA-A: 02*01+) were obtained from 24 convalescent donors and 9 healthy donors prior to the FDA emergency use authorization of the Johnson & Johnson, Moderna, and Pfizer COVID-19 vaccines. The gene discussed is HLA-A; the disease is COVID-19.